Deutsche Bank
LEGN icon

Deutsche Bank’s Legend Biotech LEGN Stock Holding History

Deutsche Bank’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.02M Buy
173,993
+8,973
+5% +$242K ﹤0.01% 1382
2026
Q1 		$2.99M Buy
165,020
+7,986
+5% +$152K ﹤0.01% 1563
2025
Q4 		$3.41M Buy
157,034
+13,277
+9% +$380K ﹤0.01% 1500
2025
Q3 		$4.69M Buy
143,757
+19,780
+16% +$730K ﹤0.01% 1340
2025
Q2 		$4.4M Sell
123,977
-14,679
-11% -$476K ﹤0.01% 1299
2025
Q1 		$4.7M Buy
138,656
+3,589
+3% +$129K ﹤0.01% 1274
2024
Q4 		$4.4M Buy
135,067
+14,198
+12% +$588K ﹤0.01% 1398
2024
Q3 		$5.89M Buy
120,869
+237
+0.2% +$12.6K ﹤0.01% 1213
2024
Q2 		$5.34M Sell
120,632
-13,499
-10% -$623K ﹤0.01% 1222
2024
Q1 		$7.52M Sell
134,131
-4,388
-3% -$265K ﹤0.01% 1123
2023
Q4 		$8.33M Buy
138,519
+32,764
+31% +$2.08M ﹤0.01% 1068
2023
Q3 		$7.1M Sell
105,755
-126,601
-54% -$8.79M ﹤0.01% 946
2023
Q2 		$16M Buy
232,356
+84,278
+57% +$5.51M 0.01% 855
2023
Q1 		$7.14M Sell
148,078
-1,898
-1% -$92.8K ﹤0.01% 1092
2022
Q4 		$7.49M Sell
149,976
-63,900
-30% -$3.1M ﹤0.01% 1078
2022
Q3 		$8.73M Buy
213,876
+2,034
+1% +$95.5K 0.01% 1002
2022
Q2 		$11.7M Sell
211,842
-32,243
-13% -$1.36M 0.01% 944
2022
Q1 		$8.87M Buy
244,085
+34,258
+16% +$1.35M ﹤0.01% 1142
2021
Q4 		$9.78M Buy
209,827
+104,872
+100% +$5.32M ﹤0.01% 1118
2021
Q3 		$5.31M Buy
104,955
+97,285
+1,268% +$4.05M ﹤0.01% 1474
2021
Q2 		$314K Buy
7,670
+2,477
+48% +$84.2K ﹤0.01% 3519
2021
Q1 		$151K Hold
5,193
– – ﹤0.01% 3777
2020
Q4 		$147K Sell
5,193
-4
-0.1% -$115 ﹤0.01% 3633
2020
Q3 		$160K Sell
5,197
-243
-4% -$8.18K ﹤0.01% 3330
2020
Q2 		$232K Buy
+5,440
New +$213K ﹤0.01% 3070

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Deutsche Bank's LEGN Position: Q2 2026 in Review

Deutsche Bank increased its Legend Biotech (LEGN) stake by 5.4% in Q2 2026, buying an estimated $242K and bringing the position to 173,993 shares worth $5.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

Deutsche Bank first reported a position in LEGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $16M in Q2 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Deutsche Bank held 173,993 shares of Legend Biotech worth $5.02M as of Q2 2026.
  • Deutsche Bank bought 8,973 Legend Biotech shares in Q2 2026, an estimated $242K.
  • Legend Biotech made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1382 holding.
  • Deutsche Bank first reported a position in Legend Biotech in Q2 2020 and has held it in 25 quarters since.
  • Deutsche Bank's Legend Biotech position peaked at $16M in Q2 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.